↓ Skip to main content

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy…

Overview of attention for article published in BMC Cancer, August 2020
Altmetric Badge

Mentioned by

reddit
1 Redditor

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
65 Mendeley
Title
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
Published in
BMC Cancer, August 2020
DOI 10.1186/s12885-020-07264-8
Pubmed ID
Authors

Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brückner, Daniel Wilhelm Mueller, Michael Thomas, Stefan Rieken

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 11%
Student > Doctoral Student 7 11%
Student > Master 6 9%
Student > Ph. D. Student 6 9%
Other 5 8%
Other 12 18%
Unknown 22 34%
Readers by discipline Count As %
Medicine and Dentistry 15 23%
Nursing and Health Professions 4 6%
Biochemistry, Genetics and Molecular Biology 3 5%
Economics, Econometrics and Finance 2 3%
Computer Science 2 3%
Other 13 20%
Unknown 26 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2020.
All research outputs
#20,638,370
of 23,232,430 outputs
Outputs from BMC Cancer
#6,578
of 8,420 outputs
Outputs of similar age
#341,361
of 399,267 outputs
Outputs of similar age from BMC Cancer
#106
of 153 outputs
Altmetric has tracked 23,232,430 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,420 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,267 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 153 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.